News · Jul 3, 2025

Great news to share! A notable recognition for Dr. Ethel Feleder

Dr. Ethel Feleder, Director of FP Clinical Pharma, has been selected by ANMAT to join the Network of Experts in Pharmacological Clinical Research.

Her new role as a member of the Advisory Committee involves providing specialized scientific advice to the National Health Authority.

A recognition that reaffirms her track record, commitment and excellence in the field of clinical research.

Congratulations, Dr. Feleder, on this honorable appointment! A source of pride for the entire F.P. Clinical Pharma team.

View official list of experts (ANMAT)

Back to News

Related news

Jan 21, 2026

ANMAT regulatory update – Bioequivalence/Bioavailability

On 01/20/2026, ANMAT Salud published Disposition 47/2026 in the Official Gazette, updating the list of APIs that must undergo bioequivalence/bioavailability studies.

Read more
May 5, 2025

Why is demonstrating bioequivalence essential for generic medicines?

Bioequivalence affects not only treatment quality, but also everyday clinical decisions.

Read more